Market Size and Growth: Analysis of the current market size and projections for the cancer monoclonal antibody market from 2023 to 2032. This includes data on market value and volume, as well as the ...

Pharmacists play a crucial role in managing treatment with chimeric antigen receptor T-cell therapy and bispecific antibodies, focusing on patient selection and side effects, explained Eileen Peng, ...

The global monoclonal antibodies market is poised for robust expansion, projected to surge from USD 208.32 billion in 2022 to USD 647.01 billion by 2032, reflecting a CAGR of 12% over the forecast ...

The advent of novel cancer care therapies such as chimeric antigen receptor T-cell therapy and bispecific antibodies is ...

Researchers from the Centenary Institute, in collaboration with the University of Sydney, have developed a powerful new tool ...

In recent years, the therapeutic landscape for hematological malignancies has undergone a profound transformation, driven by ...

Spanish scientists documented a second so-called class switch in people with "repeated" mRNA COVID jabs, meaning their bodies start churning out two kinds of antibodies that learn to live with ...

This discovery has fueled new strategies that incorporate antibodies and gene editing ... foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails ...

Serum antibody levels were sustained longer after the fourth infusion than after the first, and were higher in responders and in patients with lower tumor burden. The majority of adverse events ...